Showing 17 of 17 recruiting trials for “Combined hepatocellular carcinoma and cholangiocarcinoma”
Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis
DEB-TACE vs cTACE in HCC After TIPS
Continuation of First-line Therapy With Radiotherapy Versus Early Switch to Second-line Therapy in Oligoprogressive HCC
👨⚕️ Jinbo Yue, Doctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Jul 2025View details ↗
A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma
Enrolling by InvitationNCT06624189 ↗
Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
RecruitingNCT06342414 ↗
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
RecruitingNCT06261047 ↗
Radiotherapy Delays Second-line Drug Therapy for Oligo Progressive Primary Liver Cancer
👨⚕️ jibo yue, dorctor, Shandong Cancer Hospital and Institute📍 1 site📅 Started Mar 2024View details ↗
National Liver Cancer Screening Trial
👨⚕️ Amit Singal, MD, MS, University of Texas Southwestern Medical Center📍 18 sites📅 Started Dec 2023View details ↗
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
Enrolling by InvitationNCT05429190 ↗
Validation of SMS Protocol for HCC Screening in High-risk Patients
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
The Application of Serum DNA Methylation for Patients With HCC
👨⚕️ Po-Yueh Chen, M.D, Ditmanson Medical Foundation Chiayi Christian Hospital📍 1 site📅 Started Mar 2023View details ↗
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
TARGETed Therapy Drug MONITOring in DIGestive Oncology
TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors
Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →